Anat Loewenstein

Medicine & Life Sciences

1. Eye 100%
2. Macular Edema 87%
3. Macular Degeneration 73%
4. Visual Acuity 51%
5. Intravitreal Injections 36%
6. Optical Coherence Tomography 36%
7. Vascular Endothelial Growth Factor A 34%
8. Retina 31%
9. Bevacizumab 30%
10. Diabetic Retinopathy 29%
11. Retinal Vein Occlusion 29%
12. Dexamethasone 29%
13. Choroidal Neovascularization 26%
14. Retinal Detachment 24%
15. Subretinal Fluid 22%
16. Injections 21%
17. Photorefractive Keratectomy 21%
18. Vitrectomy 19%
19. Ranibizumab 19%
20. Therapeutics 18%
21. Intraocular Pressure 18%
22. Ocular Vision 17%
23. Rabbits 16%
24. Retinal Diseases 16%
25. Lasers 15%
26. Retinal Perforations 15%
27. Myopia 13%
28. Excimer Lasers 13%
29. Temazepam 13%
30. Ophthalmology 12%
31. aflibercept 12%
32. Endophthalmitis 11%
33. Pharmaceutical Preparations 11%
34. Safety 10%
35. Epiretinal Membrane 10%
36. Ophthalmologists 9%
37. Angiography 9%
38. Pandemics 9%
39. Central Serous Chorioretinopathy 8%
40. Cataract 8%
41. Visual Evoked Potentials 7%
42. Eye Diseases 7%
43. Optic Disk 7%
44. Corneal Transplantation 7%
45. Retinal Pigments 7%
46. Fluocinolone Acetonide 6%
47. Proliferative Vitreoretinopathy 6%
48. Geographic Atrophy 6%
49. Blood Flow Velocity 6%
50. brolucizumab 6%